Progenics Pharmaceuticals Inc. (PGNX) tumbled -5.97% or -0.32 to $5.04. It is around 610067 shares traded, which is 46.41% compare to the average total volume 1.31 million. The market cap of PGNX is $426.09 million. The year to date change is -18.82%. The 52 week price range is from $4.67 to $9.42. Price of PGNX have changed 3.28% during last week. It have changed 8.28% over last month, -33.50% over last 3 months, -28.44% over last 6 months and -0.19% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PGNX is 5.61. It is 11.31% above current price. The 200-day Moving Averages for PGNX is 7.11. It is 41.07% above current price. The 52-week High is 9.42. It is 86.90% from the current price. The 52-week Low is 4.67. It is -7.34% from current price.
There are some statistics of PGNX. It is has market cap $426.09 million. The share outstanding is 84.54 million. The average volume is 1.31 million. The percent of top 15 Institution holding is 102.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PGNX is -63.80%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PGNX is -33.33%.